| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.24 | 1e-13 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.21 | 6e-10 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-09 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.18 | 6e-09 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-08 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.18 | 3e-08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-07 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-07 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-07 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-07 |